These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6980565)

  • 21. Effector immune mechanisms in cancer.
    Lotzová E
    Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
    [No Abstract]   [Full Text] [Related]  

  • 22. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells].
    Thränhardt H; Soeberdt R; König A; Zintl F; Metz O; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):831-42. PubMed ID: 6200394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of antibody-dependent cell-mediated cytotoxicity by anti-immunoglobulin. I. Relationship to target cell capping.
    Halloran PF; Stylianos SK
    Clin Exp Immunol; 1980 Oct; 42(1):127-35. PubMed ID: 6970095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.
    Ward RH; Lachmann PJ
    Immunology; 1985 Sep; 56(1):179-88. PubMed ID: 4043993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine antithymocyte globulin T-cell depletion is mediated predominantly by macrophages, but the Fas/FasL pathway selectively targets regulatory T cells.
    Neff KS; Richards SM; Williams JM; Garman RD; Ruzek MC
    Transplantation; 2011 Sep; 92(5):523-8. PubMed ID: 21804441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptors for immunoglobulins and activation markers on human T lymphocytes.
    Moretta A; Mingari MC; Corte G; Moretta L
    Clin Haematol; 1982 Oct; 11(3):697-709. PubMed ID: 6217008
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of the immune response in the pathogenesis of primary biliary cirrhosis.
    James SP; Vierling JM; Strober W
    Semin Liver Dis; 1981 Nov; 1(4):322-37. PubMed ID: 7051311
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities.
    Kumagai K; Itoh K; Suzuki R; Hinuma S; Saitoh F
    J Immunol; 1982 Jul; 129(1):388-94. PubMed ID: 6979572
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of the role of protein synthesis in cell-mediated cytotoxic reactions.
    Laux DC; Moody CE; Parker B; Tunticharoen M
    Cell Immunol; 1978 Sep; 39(2):366-73. PubMed ID: 308859
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic responses to a murine mammary adenocarcinoma: in vitro production of specific killer cells is dependent on active T lymphocytes.
    Yamamura Y
    J Immunol; 1978 Jan; 120(1):286-92. PubMed ID: 75226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
    Santoli D; Francis MK; Matera L
    Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytotoxic activity of the effector cells as a factor in protective immunity in helminthiases (a review of the literature)].
    Leĭkina ES
    Med Parazitol (Mosk); 1983; 52(2):58-65. PubMed ID: 6343821
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells.
    Kurane I; Hebblewaite D; Ennis FA
    Immunology; 1986 Jul; 58(3):429-36. PubMed ID: 3089915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergistic cytotoxic effects of antibodies directed against different cell surface determinants.
    Elliott EV; Pindar A; Stevenson FK; Stevenson GT
    Immunology; 1978 Mar; 34(3):405-9. PubMed ID: 76604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic responses induced by peptidoglycans with or without in vivo antitumor activity.
    Goguel AF; Payelle B; Lespinats G; Nauciel C
    J Natl Cancer Inst; 1983 Aug; 71(2):325-30. PubMed ID: 6603557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult T-cell leukemia cells as effector cells in natural killer cell and antibody-dependent cellular cytotoxicity assays.
    Shimamoto Y; Sato H; Okada Y; Motomura S; Ibayashi H
    Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):136-42. PubMed ID: 6611009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.